Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,091.35
-19 (-1.71%)
BSENSE

Nov 20

BSE+NSE Vol: 2.5 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,091.35",
    "chg": -19,
    "chgp": "-1.71%",
    "dir": -1,
    "prev_price": "1,110.35",
    "mcapval": "5,126.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544319,
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0RB801010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.5 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/senores-pharmaceuticals-ltd-faces-mixed-technical-signals-amid-price-momentum-shift-4267600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SenoresPharmace_technicaldot_4267600.png",
        "date": "2026-11-19 08:06:16",
        "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a period of consolidation after recent volatility."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4263159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SenoresPharmace_technicaldot_4263159.png",
        "date": "2026-11-16 08:04:44",
        "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite a recent dip in price, the stock’s technical indicators present a complex picture, with some metrics signalling caution while others suggest potential for moderate upside. Investors and analysts are closely monitoring these developments amid a backdrop of strong year-to-date returns and evolving market dynamics."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4256639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SenoresPharmace_mojoScore_4256639.png",
        "date": "2026-11-09 10:10:56",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 November 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing."
      },
      {
        "title": "Senores Pharmaceuticals Gains 2.24%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/senores-pharmaceuticals-gains-224-3-key-factors-driving-the-weeks-momentum-4254882",
        "imagepath": "",
        "date": "2026-11-07 10:02:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Valuation adjusted amid price correction and peer comparison</p>\n                    <p><strong>3 Nov:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>4 Nov:</strong> Technical momentum shifts to mildly bullish stance</p>\n                    <p><strong>6 Nov:</strong> Week closes at ₹1,158.95 (+2.24%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,133.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹1,158.95</div><..."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-4244218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SenoresPharmace_priceRelatedfactors_4244218.png",
        "date": "2026-10-30 09:57:21",
        "description": "Senores Pharmaceuticals Ltd experienced significant intraday weakness on 30 Oct 2026, with its stock price touching a low of Rs 1,077.6, marking an 11.57% decline from previous levels. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-4243642",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SenoresPharmace_priceRelatedfactors_4243642.png",
        "date": "2026-10-29 15:02:07",
        "description": "Senores Pharmaceuticals Ltd experienced a significant intraday decline on 29 Oct 2026, with its stock price touching a low of Rs 1,215, marking an 8.24% drop. This downturn contrasts sharply with the broader market’s positive momentum, reflecting immediate pressures on the small-cap pharmaceutical firm."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4240656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SenoresPharmace_mojoScore_4240656.png",
        "date": "2026-10-27 10:10:57",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-4227686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SenoresPharmace_mojoScore_4227686.png",
        "date": "2026-10-16 10:10:53",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 October 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-4214536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SenoresPharmace_mojoScore_4214536.png",
        "date": "2026-10-05 10:10:36",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 October 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 114,
    "sid": "10039497",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
      "datetime": "18-Nov-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinizer Report dated November 17 2026",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "18-Nov-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Regulation 30 Disclosure Regarding Issuance Of Certificate Of GMP Compliance By The State Service Of Ukraine On Medicines And Drugs Control",
      "datetime": "17-Nov-2026",
      "details": "We are pleased to announce that the manufacturing facility of our Subsidiary Company. Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification by the State service of Ukraine on Medicines and Drugs Control.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

18-Nov-2026 | Source : BSE

Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinizer Report dated November 17 2026

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

18-Nov-2026 | Source : BSE

Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot

Regulation 30 Disclosure Regarding Issuance Of Certificate Of GMP Compliance By The State Service Of Ukraine On Medicines And Drugs Control

17-Nov-2026 | Source : BSE

We are pleased to announce that the manufacturing facility of our Subsidiary Company. Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification by the State service of Ukraine on Medicines and Drugs Control.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available